Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost Sodium for AVF Patency in Hemodialysis
NCT03142360Unknown
- Sponsor
- Yonsei University
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of beraprost in arteriovenous fistula (AVF) (2 arms), sponsored by Yonsei University. Primary endpoint: Arteriovenous Fistula Maturation Rate at 3 months. Status: unknown.
02
Drugs
beraprost
03
Conditions
arteriovenous fistula (AVF)
Beyond the preview
Go deeper on NCT03142360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142360.